{"result": {"id": "9e5c726b-001b-418e-bb82-00bea0b10ac9", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>非致死性心肌梗死<|>event<|>非致死性心肌梗死是一种心血管事件，抗血小板治疗可降低其发生率约1/3\")  \n##\n(\"entity\"<|>非致死性脑卒中<|>event<|>非致死性脑卒中是一种脑血管事件，抗血小板治疗可降低其发生率约1/4\")  \n##\n(\"entity\"<|>致死性血管事件<|>event<|>致死性血管事件是严重的心血管事件，抗血小板治疗可降低其发生率约1/6\")  \n##\n(\"entity\"<|>急性冠脉综合征<|>event<|>急性冠脉综合征是血栓症急性发作的一种，需要阿司匹林联合P2Y12受体抑制剂治疗\")  \n##\n(\"entity\"<|>缺血性脑卒中<|>event<|>缺血性脑卒中是需要抗血小板治疗的急性血栓症\")  \n##\n(\"entity\"<|>短暂性脑缺血<|>event<|>短暂性脑缺血是需要抗血小板治疗的急性血栓症\")  \n##\n(\"entity\"<|>闭塞性周围动脉粥样硬化症<|>event<|>闭塞性周围动脉粥样硬化症是需要抗血小板治疗的急性血栓症\")  \n##\n(\"entity\"<|>P2Y12受体抑制剂<|>organization<|>P2Y12受体抑制剂是一类抗血小板药物，包括氯吡格雷和替格瑞洛\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>非致死性心肌梗死<|>抗血小板治疗可降低非致死性心肌梗死风险<|>7\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>非致死性脑卒中<|>抗血小板治疗可降低非致死性脑卒中风险<|>7\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>致死性血管事件<|>抗血小板治疗可降低致死性血管事件风险<|>7\")  \n##\n(\"relationship\"<|>急性冠脉综合征<|>阿司匹林<|>阿司匹林用于急性冠脉综合征的治疗<|>8\")  \n##\n(\"relationship\"<|>缺血性脑卒中<|>阿司匹林<|>阿司匹林用于缺血性脑卒中的治疗<|>8\")  \n##\n(\"relationship\"<|>短暂性脑缺血<|>阿司匹林<|>阿司匹林用于短暂性脑缺血的治疗<|>8\")  \n##\n(\"relationship\"<|>闭塞性周围动脉粥样硬化症<|>阿司匹林<|>阿司匹林用于闭塞性周围动脉粥样硬化症的治疗<|>8\")  \n##\n(\"relationship\"<|>P2Y12受体抑制剂<|>氯吡格雷<|>氯吡格雷是一种P2Y12受体抑制剂<|>9\")  \n##\n(\"relationship\"<|>P2Y12受体抑制剂<|>替格瑞洛<|>替格瑞洛是一种P2Y12受体抑制剂<|>9\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558678, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 652, "prompt_tokens": 3069, "total_tokens": 3721, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3008}, "prompt_cache_hit_tokens": 3008, "prompt_cache_miss_tokens": 61}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 抗血小板治疗在心脑血管疾病二级预防中的作用 已被大量临床研究证实 ,可有效降低心血管事件风险 19%~25% ,其中非致死性心肌梗死下降 1/3,非致死 性脑卒中下降 1/4,致死性血管事件下降 1/6[349-350] 。\n　　　下列高血压患者应积极抗血小板治疗 :①高血压合 并 ASCVD患者 ,需应用小剂量阿司匹林(100mg/d)进 行长期二级预防[252,351] ;②合并血栓症急性发作 ,如急 性冠脉综合征、缺血性脑卒中或短暂性脑缺血、闭塞性 周围动脉粥样硬化症时 ,应按相关指南的推荐使用阿 司匹林合用 1种 P2Y12受体抑制剂 。P2Y12受体抑 制剂选择包括氯吡格雷和替格瑞洛 ,通常在急性期可 给予负荷 剂 量 1 次(阿 司 匹 林 : 300 mg,氯 吡 格 雷 : 300~ 600 mg 或 替 格 瑞 洛  180  mg) , 阿 司 匹 林 (100mg/d) 和 氯 吡 格 雷 ( 75 mg/d) 或 替 格 瑞 洛 (180mg/d)联合应用 3~12月 ,而后应用小剂量阿司 匹林(100mg/d) 或 P2Y12受体抑制剂作为长期二级 预防。\n　　　现有证据提示 , 阿司匹林用于 ASCVD一级预防 应基于临床获益和风险比 ,进行个体化治疗 。抗血小 板治疗对心脑血管疾病一级预防的获益主要体现在高 危人群[352-354]  ,如高血压伴糖尿病、高血压伴 CKD、心 血管疾病高风险(10年心血管疾病总风险 ≥10%或高 血压合并 3项及以上其他危险因素) 且无高出血风险 的患者 。ASCVD 中低危患者 ,不推荐采用阿司匹林 进行 ASCVD一级预防[353] 。\n　　　目 前 , 建 议 阿 司 匹 林 一 级 预 防 的 剂 量 为 75~ 100mg/d[125] 。使用阿司匹林进行 ASCVD一级预防 时 ,对于年龄>70岁的患者其风险大于获益 ,不建议 常规使用[355] 。对于年龄<40岁的患者 , 目前尚缺乏 足够证据判断风险获益比 。阿司匹林不能耐受者可应 用氯吡格雷代替。\n\n\n\n　　　高 血 压 患 者 长 期 应 用 阿 司 匹 林 应 注 意[356-357]  :  ①需在血压控制稳定(<150/90mmHg) 后开始应用。 未达良好控制的高血压患者 , 阿司匹林可能增加脑出  血风险 ;②肠溶阿司匹林建议空腹服用以减少胃肠道  反应 ;③服用前有发生消化道出血的高危因素 ,如消化  道疾病(溃疡病及其并发症史) , 65岁以上 , 同时服用  皮质类固\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>抗血小板治疗<|>event<|>抗血小板治疗是一种用于心脑血管疾病二级预防的治疗方法，已被临床研究证实可有效降低心血管事件风险\")  \n##\n(\"entity\"<|>阿司匹林<|>organization<|>阿司匹林是一种抗血小板药物，用于心脑血管疾病的二级预防和一级预防，常用剂量为75-100mg/d\")  \n##\n(\"entity\"<|>氯吡格雷<|>organization<|>氯吡格雷是一种P2Y12受体抑制剂，用于急性冠脉综合征等血栓症急性发作时的抗血小板治疗\")  \n##\n(\"entity\"<|>替格瑞洛<|>organization<|>替格瑞洛是一种P2Y12受体抑制剂，用于急性冠脉综合征等血栓症急性发作时的抗血小板治疗\")  \n##\n(\"entity\"<|>ASCVD<|>event<|>ASCVD（动脉粥样硬化性心血管疾病）是一种需要抗血小板治疗进行二级预防的疾病\")  \n##\n(\"entity\"<|>高血压<|>event<|>高血压患者在某些情况下需要积极抗血小板治疗，如合并ASCVD或血栓症急性发作\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>阿司匹林<|>阿司匹林是抗血小板治疗的主要药物之一<|>8\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>氯吡格雷<|>氯吡格雷是抗血小板治疗的另一种药物选择<|>7\")  \n##\n(\"relationship\"<|>抗血小板治疗<|>替格瑞洛<|>替格瑞洛是抗血小板治疗的另一种药物选择<|>7\")  \n##\n(\"relationship\"<|>阿司匹林<|>氯吡格雷<|>阿司匹林和氯吡格雷可以联合用于急性期抗血小板治疗<|>6\")  \n##\n(\"relationship\"<|>阿司匹林<|>替格瑞洛<|>阿司匹林和替格瑞洛可以联合用于急性期抗血小板治疗<|>6\")  \n##\n(\"relationship\"<|>高血压<|>阿司匹林<|>高血压患者在特定情况下需要使用阿司匹林进行抗血小板治疗<|>5\")  \n##\n(\"relationship\"<|>ASCVD<|>阿司匹林<|>阿司匹林用于ASCVD的二级预防和一级预防<|>7\")  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_3e9c702a573038b31a1daf82815cd9addad7f4ccc2df7d89349f2cb3b83f1858_v2"}